Acrux (ASX:ACR) ROE % Adjusted to Book Value : -49.62% (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Acrux ROE % Adjusted to Book Value?

Acrux's ROE % for the quarter that ended in Dec. 2024 was -204.94%. Acrux's PB Ratio for the quarter that ended in Dec. 2024 was 4.13. Acrux's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -49.62%.

Acrux ROE % Adjusted to Book Value Historical Data

The historical data trend for Acrux's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux ROE % Adjusted to Book Value Chart

Acrux Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-28.51

-40.32

-43.78

-6.14

-15.45

Acrux Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-26.26	49.26	-38.96	-18.33	-49.62

Competitive Comparison of Acrux's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Acrux's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acrux's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrux's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Acrux's ROE % Adjusted to Book Value falls into.

Acrux ROE % Adjusted to Book Value Calculation

Acrux's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-96.89%	/	6.27
	=	-15.45%

Acrux's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-204.94%	/	4.13
	=	-49.62%

Acrux ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Acrux's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrux Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (ASX:ACR) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003

Website

https://www.acrux.com.au

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.